STERIS plc
STERIS plc (STE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · STE · as of Jun 8, 2026
Key Statistics
Explore STERIS plc Data
ste stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 84.6%
The STE analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $269.50, representing +26.91% upside from the current price of $212.35.
Competitors & Peers
ste competitorsSTE
BIIB
DGX
DXCM
LH
PHGStock Performance
Full HistoryAbout STERIS plc
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Den…
what is steris plc · ste stock overview · steris plc company profile · who is steris plc ceo · ste NYSE · steris plc headquarters · steris plc business segments
About Stock Overview & Key Data
STERIS plc (STE) is a Healthcare company in the Medical - Devices industry, listed on NYSE since Jun 1, 1992. As of the latest trading session, STE stock price is $212.35, with a market capitalization of $20.7B. The stock has returned -12.51% over the past 12 months and -16.24% year-to-date.
According to 13 Wall Street analysts, the consensus rating for STERIS plc stock is Buy, with an average 12-month price target of $269.50. In fiscal year 2026, STERIS plc reported revenue of $5.9B and net income of $785.1M. For detailed data — including STERIS plc revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, STERIS plc (STE) stock price is $212.35. The stock is traded on NYSE under the ticker symbol STE. The 52-week range is $195.14 – $269.44.